Patents by Inventor Dillon Phan

Dillon Phan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250034267
    Abstract: Materials and methods for using polypeptides containing fragments and variants of the antibody(ies) or portion(s) thereof that bind CD25 to treat cancer alone or in combination with other anti-neoplastic agents.
    Type: Application
    Filed: September 4, 2024
    Publication date: January 30, 2025
    Inventors: Dillon Phan, Martin Brenner, Brian Berquist, Peter Kipp, Tam Phuong, Kevin Babilonia, Tom Hsu, Lufei Hu, James Talmage Taylor, JR., Cory Schwartz
  • Publication number: 20250019457
    Abstract: Provided herein are anti-Trop 2 antibodies or binding fragments thereof that bind Trop 2, e.g., human Trop 2. The anti-Trop 2 antibodies of the disclosure are useful for the treatment of proliferative disorders or cells that express Trop 2 or mutant Trop 2. Also provided herein are methods of use for the anti-Trop 2 antibodies or binding fragments thereof, as well as bi-valent or multi-valent anti-Trop 2 antibodies or binding fragments thereof that may form complexes that attract immune effectors or binding to other cells, such as, a second antibody, antigen-binding of the second antibody or fragment thereof; a target-binding protein, a cytokine; a lectin; or a toxin.
    Type: Application
    Filed: June 28, 2024
    Publication date: January 16, 2025
    Inventors: Dillon Phan, Cory Schwartz, Matthew P. Greving, Cody A. Moore, Tam Thi Thanh Phuong, Matthew Dent, Alexander T. Taguchi, Jiang Chen, Tom Sih-Yuan Hsu, Domyoung Kim, Martin Brenner
  • Patent number: 12129302
    Abstract: Materials and methods for using polypeptides containing fragments and variants of the antibody(ies) or portion(s) thereof that bind CD25 to treat cancer alone or in combination with other anti-neoplastic agents.
    Type: Grant
    Filed: August 22, 2022
    Date of Patent: October 29, 2024
    Assignee: iBio, Inc.
    Inventors: Dillon Phan, Martin Brenner, Brian Berquist, Peter Kipp, Tam Phuong, Kevin Babilonia, Tom Hsu, Lufei Hu, James Talmage Taylor, Jr., Cory Schwartz
  • Publication number: 20240228637
    Abstract: Provided herein are anti-CCR8 antibodies or antigen binding fragment thereof, which bind to CCR8, wherein the CCR8 is a human CCR8 and the antibody does not bind human CCR4. The anti-CCR8 antibodies or antigen binding fragment of the disclosure are useful for the treatment of cancer diseases through the elimination of regulatory T cells. Also provided herein are methods of use for the anti-CCR8 antibodies or antigen binding fragment thereof.
    Type: Application
    Filed: October 19, 2023
    Publication date: July 11, 2024
    Inventors: Dillon Phan, Tom Sih-Yuan Hsu, Tam Thi Thanh Phuong, Matthew P. Greving, Alexander Tomoaki Taguchi, Cory Schwartz, Jiang Chen, Gao Liu, Martin Brenner, Matthew William Dent, Cody Allen Moore
  • Publication number: 20240132604
    Abstract: Provided herein are anti-CCR8 antibodies or antigen binding fragment thereof, which bind to CCR8, wherein the CCR8 is a human CCR8 and the antibody does not bind human CCR4. The anti-CCR8 antibodies or antigen binding fragment of the disclosure are useful for the treatment of cancer diseases through the elimination of regulatory T cells. Also provided herein are methods of use for the anti-CCR8 antibodies or antigen binding fragment thereof.
    Type: Application
    Filed: October 18, 2023
    Publication date: April 25, 2024
    Inventors: Dillon Phan, Tom Sih-Yuan Hsu, Tam Thi Thanh Phuong, Matthew P. Greving, Alexander Tomoaki Taguchi, Cory Schwartz, Jiang Chen, Gao Liu, Martin Brenner, Matthew William Dent, Cody Allen Moore
  • Publication number: 20240117056
    Abstract: Provided herein are anti-EGFRvII antibodies and binding fragments thereof. The anti-EGFRvIII antibodies of the disclosure are useful for the treatment of cancers through, e.g., antibody-dependent cell cytotoxicity (ADCC). Also provided herein are methods of making and using the anti-EGFRvIII antibodies for the treatment of cancer, and polynucleotides that encode the same.
    Type: Application
    Filed: October 11, 2023
    Publication date: April 11, 2024
    Inventors: Dillon Phan, Tom Sih-Yuan Hsu, Matthew P. Greving, Martin Brenner, Tam Thi Thanh Phuong, Alexander Tomoaki Taguchi, Cory Schwartz, Gao Liu, Jiang Chen
  • Publication number: 20230159646
    Abstract: Materials and methods for using polypeptides containing fragments and variants of the antibody(ies) or portion(s) thereof that bind CD25 to treat cancer alone or in combination with other anti-neoplastic agents.
    Type: Application
    Filed: August 22, 2022
    Publication date: May 25, 2023
    Inventors: Dillon Phan, Martin Brenner, Brian Berquist, Peter Kipp, Tam Phuong, Kevin Babilonia, Tom Hsu, Lufei Hu, James Talmage Taylor, JR., Cory Schwartz